LBA01-09 INTERIM ANALYSIS NCT04046094: IV VITAMIN C WITH CHEMOTHERAPY FOR CISPLATIN INELIGIBLE BLADDER CANCER PATIENTS (CI-MIBC). (May 2022) - Taylor, John